Amazon certainly has been a leading e-commerce innovator over the last 20 years, and many people have benefited from the immense services they offer. But while their company has been a great resource for retail shoppers and digital streaming customers, they’ve been a nightmare for certain companies and their stockholders. A particular area they’re now causing grave concern in is the healthcare industry because they’re now putting together a plan that could disrupt it altogether by changing how pharmaceuticals are distributed to consumers.
Paul Mampilly is an investor who’s taken great interest in Amazon’s development because he writes newsletters to thousands of followers that explain how you can buy stocks and which kind you should look into. What he’s saying about Amazon’s healthcare plans are that they’re going to cut out all the middlemen that normally come between a pharmaceutical and its delivery to a drug store shelf. This is a big deal because that middleman is where much of the main pharmacy companies and manufacturers profit from and it affects their stock prices. Amazon’s targeting of those stocks and bringing of transparency into the industry may be good for some middle class Americans who struggle to afford health insurance and prescription costs, but it’s bad for stockholders because this could cause a sudden downturn in stock prices that they may never recover from. Mampilly is urging his followers not to buy falling healthcare stocks even if they look like a very good deal.
Paul Mampilly has been writing newsletters at an independent investment advisory news company known as Banyan Hill for a couple years now, but he had made a name for himself on Wall Street for more than 20 years prior to that. He began his career at Deutsche Bank after receiving a bachelor’s degree in finance from Montclair State University, and he became a savvy investor after several years as an adept researcher. He became a major account manager for ING and Banker’s Trust in the years following this, and in 2006 he started directing hedge funds at Kinetics International Fund. In just the first few months he attracted so many clients to the firm that its AUM rose from $6 billion to $25 billion, and Barron’s gave him recognition for making annual returns on investments at 26%. He also won the competition at the Templeton Foundation while employed at the firm.
Paul Mampilly’s ultimate goal was not to help the Wall Street clients but instead to help the working people of America learn how to gain financial independence by investing on their own, so he left his New York office and moved down to a more smaller town in North Carolina in 2012. He stayed low key for a few years but then announced his newsletter at Banyan Hill in 2016 and shocked many of his initial readers when he mentioned the gains they could make in the stock market. But as many of them started putting his advice to use, they realized it was legitimate and many started raving about the gains they had made in user reviews. Mampilly is all about transparency and gives his readers an over-the-shoulder look at his investments so they can see how he runs them.